SlideShare a Scribd company logo
GROUP PRESENTATION
Group A
GROUP MEMBERS
 Issra Naz. 1364-
FBAS/BSBT/F20
 Aimen Tehreem 1369-
FBAS/BSBT/F20
 Sameen Anosha 1398-
FBAS/BSBT/F20​
 Humaira Faisal 1401-
FBAS/BSBT/F20
Course: Virology
Course code: BT 301
Presentation topic: Corona virus
Submitted to: Dr. Kehkashan
Presentation title
CORONA VIRUS
DEFINITION
Highly contagious A respiratory disease caused by the SARS-CoV-2 virus.
SARS-CoV-2 is thought to spread from person to person through droplets
released when an infected person coughs, sneezes, or talks.
5
OUTBREAK
 It was first identified amid an outbreak of respiratory illness cases in
Wuhan City, Hubei Province, China.
 It was initially reported to the WHO on December 31, 2019.
 On January 30, 2020, the WHO declared the COVID-19 outbreak a global
health emergency.
 On March 11, 2020, the WHO declared COVID-19 a global pandemic, its
first such designation since declaring H1N1 influenza a pandemic in 2009.
 Illness caused by SARS-CoV-2 was termed COVID-19 by the WHO, the
acronym derived from "coronavirus disease 2019.
MORPHOLOGY
 Coronaviruses are enveloped, pleomorphic or spherical particles, 150 nm to 160 nm in size,
linked with constructive single stranded RNA, unsegmented, nucleoprotein, capsid, matrix,
and surface glycoprotein (S-protein).
 Significant viral proteins are nucleocapsid protein (N), membrane (M), spike glycoprotein
(S), and envelope small membrane protein (E).
 COVID-19 varies from further coronaviruses by encoding a supplementary glycoprotein that
Esterase and Hemagglutination (HE) properties.
Structural protein Function(s) of protein
Nucleocapsid protein (N)
Bound to RNA genome to make up
nucleocapsid
Spike glycoprotein (S)
Critical for binding of host cell receptors to
facilitate entry of host cell
Envelope small membrane protein (E) Interacts with M to form viral envelope
Membrane protein (M)
Central organizer of CoV assembly
Determines shape of viral envelope
Hemagglutinin-Esterase (HE) Forms a distinct inner fringe of short peplomer
SYMPTOMS
Most common symptoms:
 Fever
 Cough
 Tiredness
 loss of taste or smell
Less common symptoms:
 Sore throat
 Headache
 Aches and pains
 Diarrhoea
 Rash on skin,
 Discolouration of fingers toes
 Red or irritated eyes
Serious symptoms:
 Difficulty breathing or shortness of breath
 Loss of speech or mobility, or confusion chest
pain
 Seek immediate medical attention if you have
serious symptoms.
 People with mild symptoms who are otherwise
healthy should manage their symptoms at
home.
 On average it takes 5–6 days from when
someone is infected with the virus for symptoms
to show, however it can take up to 14 days.
LIFE CYCLE OF COVID 19
1. Infection:
So the first thing a virus has to do is to find a way to attach itself to a cell so that
it can specifically get into the cell. That’s the Virus Receptor Interactions and for SARS-CoV-2
it binds to a protein called ACE-2(Angiotensin-converting enzyme 2) that is on the surface of
some cells but not all cells.
2. Internalisation:
Viruses then have to get inside a cell and in case of SARS- Covid it has a sort of
membrane around it (Viral Lipid Membrane) that hides its genetic material from outside world.
Our cells have Same kind of membrane around them that hides their genetic material from
outside world.
3. Membrane fusion and
Release of viral RNA:
The virus genome when
enters a cell start to find
something in the host cell
that is called ribosomes and
ribosomes is what turns
RNA into proteins.
4. Translation:
It takes the sequence of RNA and then translates that into a protein
sequence. RNA is the mean that is used to express our genes. The more the viral
RNA that’s in the cell, the more that RNA will be translated into protein and faster
yeh virus can take over the cell. The RNA serves two purposes. It encodes the
genes that it has to complete its lifecycle but it also the way that send a message
out to the cell to say” Make More of my Gene”.
5. Packaging and assembly:
Then towards the end of the virus Cycle, the virus sends out its
protein to a particular places within the cell that are then places where the
proteins are concentrated and new virus particles are made.
Presentation title 14
TREATMENT OF COVID 19
Self care
 After exposure to someone who has COVID-19, do the following:
 Call your health care provider or COVID-19 hotline to find out where and when to get a
test.
 If testing is not available, stay home and away from others for 14 days.
 While you are in quarantine, do not go to work, to school or to public places. Ask someone
to bring you supplies.
 Keep at least a 1-metre distance from others, even from your family members.
 Wear a medical mask to protect others, including if/when you need to seek medical care.
 Clean your hands frequently.
 Stay in a separate room from other family members, and if not possible, wear a medical
mask.
 Keep the room well-ventilated.
SELF CARE
 If you share a room, place beds at least 1 meter apart.
 Monitor yourself for any symptoms for 14 days.
 Call your health care provider immediately if you have
any of these danger signs: difficulty breathing, loss of
speech or mobility, confusion or chest pain.
 Stay positive by keeping in touch with loved ones by
phone or online, and by exercising at home.
MEDICAL CARE
Scientists around the world are working to find and
develop treatments for COVID-19.
 Optimal supportive care includes oxygen for severely ill
patients and those who are at risk for severe disease
and more advanced respiratory support such as
ventilation for patients who are critically ill.
 Dexamethasone is a corticosteroid that can help reduce
the length of time on a ventilator and save lives of
patients with severe and critical illness.
18
vaccines
vaccines

More Related Content

Similar to vaccines

Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management
DrShrey Bhatia
 
Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19
abiramimcc1979
 
CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19
Dr.Hashim Syed Ali (Dr.Foster)
 
Coronavirus disease
Coronavirus disease Coronavirus disease
Coronavirus disease
sruthijoseph77
 
Pandemic covid 19 presentation
Pandemic covid 19  presentationPandemic covid 19  presentation
Pandemic covid 19 presentation
SrishtiPatel
 
PPT on corona virus by rohit vijay jirobe
PPT on corona virus by rohit vijay jirobePPT on corona virus by rohit vijay jirobe
PPT on corona virus by rohit vijay jirobe
nikhil jirobe
 
COVID_19 Corona virus
COVID_19 Corona virusCOVID_19 Corona virus
COVID_19 Corona virus
nosheensultan
 
COVID-19 | Corona Virus
COVID-19 | Corona VirusCOVID-19 | Corona Virus
COVID-19 | Corona Virus
Maneesha M Joseph
 
SARS
SARSSARS
Presentation on vaccination
Presentation on vaccinationPresentation on vaccination
Presentation on vaccination
hajra jamil
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
tulu2015
 
Relationship between SARS CoV, MERS CoV and COVID19.
Relationship between SARS CoV, MERS CoV and COVID19.Relationship between SARS CoV, MERS CoV and COVID19.
Relationship between SARS CoV, MERS CoV and COVID19.
SumitSingh1135
 
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do NowCORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
AllenLyons6
 
India fights covid 19
India fights covid 19India fights covid 19
India fights covid 19
Tajinder Singh
 
Covid 19
Covid 19Covid 19
Covid 19
omaralobaidy1
 
Public responsibilities in the fight against covid 19 by priya
Public responsibilities in the fight against covid 19 by priya  Public responsibilities in the fight against covid 19 by priya
Public responsibilities in the fight against covid 19 by priya
PriyaSathe1
 
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
MaryRoseHughesRicero
 
Corona Virus
Corona Virus Corona Virus
Corona Virus
Sheikh Mohammad Talha
 
مهم جداCoronavirus.pptx
مهم جداCoronavirus.pptxمهم جداCoronavirus.pptx
مهم جداCoronavirus.pptx
MustafaALShlash1
 
Novel coronavirus (2019 n cov)-li
Novel coronavirus (2019 n cov)-liNovel coronavirus (2019 n cov)-li
Novel coronavirus (2019 n cov)-li
Laurent Iyikirenga
 

Similar to vaccines (20)

Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management
 
Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19Covid 19 Project-1.pptx this ppt talks about covid 19
Covid 19 Project-1.pptx this ppt talks about covid 19
 
CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19
 
Coronavirus disease
Coronavirus disease Coronavirus disease
Coronavirus disease
 
Pandemic covid 19 presentation
Pandemic covid 19  presentationPandemic covid 19  presentation
Pandemic covid 19 presentation
 
PPT on corona virus by rohit vijay jirobe
PPT on corona virus by rohit vijay jirobePPT on corona virus by rohit vijay jirobe
PPT on corona virus by rohit vijay jirobe
 
COVID_19 Corona virus
COVID_19 Corona virusCOVID_19 Corona virus
COVID_19 Corona virus
 
COVID-19 | Corona Virus
COVID-19 | Corona VirusCOVID-19 | Corona Virus
COVID-19 | Corona Virus
 
SARS
SARSSARS
SARS
 
Presentation on vaccination
Presentation on vaccinationPresentation on vaccination
Presentation on vaccination
 
covid-19 corona virus
covid-19 corona virus covid-19 corona virus
covid-19 corona virus
 
Relationship between SARS CoV, MERS CoV and COVID19.
Relationship between SARS CoV, MERS CoV and COVID19.Relationship between SARS CoV, MERS CoV and COVID19.
Relationship between SARS CoV, MERS CoV and COVID19.
 
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do NowCORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
CORONAVIRUS (COVID-19) Prevention: 12 Things to Do Now
 
India fights covid 19
India fights covid 19India fights covid 19
India fights covid 19
 
Covid 19
Covid 19Covid 19
Covid 19
 
Public responsibilities in the fight against covid 19 by priya
Public responsibilities in the fight against covid 19 by priya  Public responsibilities in the fight against covid 19 by priya
Public responsibilities in the fight against covid 19 by priya
 
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
 
Corona Virus
Corona Virus Corona Virus
Corona Virus
 
مهم جداCoronavirus.pptx
مهم جداCoronavirus.pptxمهم جداCoronavirus.pptx
مهم جداCoronavirus.pptx
 
Novel coronavirus (2019 n cov)-li
Novel coronavirus (2019 n cov)-liNovel coronavirus (2019 n cov)-li
Novel coronavirus (2019 n cov)-li
 

More from BinteHawah1

T CELL RECEPTOR.pptx
T CELL RECEPTOR.pptxT CELL RECEPTOR.pptx
T CELL RECEPTOR.pptx
BinteHawah1
 
T CELL ACTIVATION.pptx
T CELL ACTIVATION.pptxT CELL ACTIVATION.pptx
T CELL ACTIVATION.pptx
BinteHawah1
 
MHC lecture.pptx
MHC lecture.pptxMHC lecture.pptx
MHC lecture.pptx
BinteHawah1
 
immuno-VDJ recombination.pptx
immuno-VDJ recombination.pptximmuno-VDJ recombination.pptx
immuno-VDJ recombination.pptx
BinteHawah1
 
hypersensitivity.pptx
hypersensitivity.pptxhypersensitivity.pptx
hypersensitivity.pptx
BinteHawah1
 
cytokines presentation 1.pptx
cytokines presentation 1.pptxcytokines presentation 1.pptx
cytokines presentation 1.pptx
BinteHawah1
 
COMPLEMENT SYSTEM.pptx
COMPLEMENT SYSTEM.pptxCOMPLEMENT SYSTEM.pptx
COMPLEMENT SYSTEM.pptx
BinteHawah1
 
B CELL RECEPTOR final.pptx
B CELL RECEPTOR final.pptxB CELL RECEPTOR final.pptx
B CELL RECEPTOR final.pptx
BinteHawah1
 
Antibody PPT BTTTT.pptx
Antibody PPT BTTTT.pptxAntibody PPT BTTTT.pptx
Antibody PPT BTTTT.pptx
BinteHawah1
 
ADAPTIVE IMMUNITY T CELLS.pptx
ADAPTIVE IMMUNITY T CELLS.pptxADAPTIVE IMMUNITY T CELLS.pptx
ADAPTIVE IMMUNITY T CELLS.pptx
BinteHawah1
 
innate immunity.pptx
innate immunity.pptxinnate immunity.pptx
innate immunity.pptx
BinteHawah1
 
immunology .pptx
immunology .pptximmunology .pptx
immunology .pptx
BinteHawah1
 
immune organs final-1.pptx
immune organs final-1.pptximmune organs final-1.pptx
immune organs final-1.pptx
BinteHawah1
 
ENDOCYTOSIS & INFLAMMATION-1.pptx
ENDOCYTOSIS & INFLAMMATION-1.pptxENDOCYTOSIS & INFLAMMATION-1.pptx
ENDOCYTOSIS & INFLAMMATION-1.pptx
BinteHawah1
 
Carbohydrates.pptx
Carbohydrates.pptxCarbohydrates.pptx
Carbohydrates.pptx
BinteHawah1
 
zika-virus-disease.pptx
zika-virus-disease.pptxzika-virus-disease.pptx
zika-virus-disease.pptx
BinteHawah1
 
Viral vectors Gene Replacement Therapy.pptx
Viral vectors Gene Replacement Therapy.pptxViral vectors Gene Replacement Therapy.pptx
Viral vectors Gene Replacement Therapy.pptx
BinteHawah1
 
Steps_of_Virus_Infections.pdf
Steps_of_Virus_Infections.pdfSteps_of_Virus_Infections.pdf
Steps_of_Virus_Infections.pdf
BinteHawah1
 
Replication of Virus.pptx
Replication of Virus.pptxReplication of Virus.pptx
Replication of Virus.pptx
BinteHawah1
 
Rabies.E.pptx
Rabies.E.pptxRabies.E.pptx
Rabies.E.pptx
BinteHawah1
 

More from BinteHawah1 (20)

T CELL RECEPTOR.pptx
T CELL RECEPTOR.pptxT CELL RECEPTOR.pptx
T CELL RECEPTOR.pptx
 
T CELL ACTIVATION.pptx
T CELL ACTIVATION.pptxT CELL ACTIVATION.pptx
T CELL ACTIVATION.pptx
 
MHC lecture.pptx
MHC lecture.pptxMHC lecture.pptx
MHC lecture.pptx
 
immuno-VDJ recombination.pptx
immuno-VDJ recombination.pptximmuno-VDJ recombination.pptx
immuno-VDJ recombination.pptx
 
hypersensitivity.pptx
hypersensitivity.pptxhypersensitivity.pptx
hypersensitivity.pptx
 
cytokines presentation 1.pptx
cytokines presentation 1.pptxcytokines presentation 1.pptx
cytokines presentation 1.pptx
 
COMPLEMENT SYSTEM.pptx
COMPLEMENT SYSTEM.pptxCOMPLEMENT SYSTEM.pptx
COMPLEMENT SYSTEM.pptx
 
B CELL RECEPTOR final.pptx
B CELL RECEPTOR final.pptxB CELL RECEPTOR final.pptx
B CELL RECEPTOR final.pptx
 
Antibody PPT BTTTT.pptx
Antibody PPT BTTTT.pptxAntibody PPT BTTTT.pptx
Antibody PPT BTTTT.pptx
 
ADAPTIVE IMMUNITY T CELLS.pptx
ADAPTIVE IMMUNITY T CELLS.pptxADAPTIVE IMMUNITY T CELLS.pptx
ADAPTIVE IMMUNITY T CELLS.pptx
 
innate immunity.pptx
innate immunity.pptxinnate immunity.pptx
innate immunity.pptx
 
immunology .pptx
immunology .pptximmunology .pptx
immunology .pptx
 
immune organs final-1.pptx
immune organs final-1.pptximmune organs final-1.pptx
immune organs final-1.pptx
 
ENDOCYTOSIS & INFLAMMATION-1.pptx
ENDOCYTOSIS & INFLAMMATION-1.pptxENDOCYTOSIS & INFLAMMATION-1.pptx
ENDOCYTOSIS & INFLAMMATION-1.pptx
 
Carbohydrates.pptx
Carbohydrates.pptxCarbohydrates.pptx
Carbohydrates.pptx
 
zika-virus-disease.pptx
zika-virus-disease.pptxzika-virus-disease.pptx
zika-virus-disease.pptx
 
Viral vectors Gene Replacement Therapy.pptx
Viral vectors Gene Replacement Therapy.pptxViral vectors Gene Replacement Therapy.pptx
Viral vectors Gene Replacement Therapy.pptx
 
Steps_of_Virus_Infections.pdf
Steps_of_Virus_Infections.pdfSteps_of_Virus_Infections.pdf
Steps_of_Virus_Infections.pdf
 
Replication of Virus.pptx
Replication of Virus.pptxReplication of Virus.pptx
Replication of Virus.pptx
 
Rabies.E.pptx
Rabies.E.pptxRabies.E.pptx
Rabies.E.pptx
 

Recently uploaded

A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 

Recently uploaded (20)

A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 

vaccines

  • 1.
  • 2. GROUP PRESENTATION Group A GROUP MEMBERS  Issra Naz. 1364- FBAS/BSBT/F20  Aimen Tehreem 1369- FBAS/BSBT/F20  Sameen Anosha 1398- FBAS/BSBT/F20​  Humaira Faisal 1401- FBAS/BSBT/F20
  • 3. Course: Virology Course code: BT 301 Presentation topic: Corona virus Submitted to: Dr. Kehkashan Presentation title
  • 5. DEFINITION Highly contagious A respiratory disease caused by the SARS-CoV-2 virus. SARS-CoV-2 is thought to spread from person to person through droplets released when an infected person coughs, sneezes, or talks. 5
  • 6. OUTBREAK  It was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China.  It was initially reported to the WHO on December 31, 2019.  On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency.  On March 11, 2020, the WHO declared COVID-19 a global pandemic, its first such designation since declaring H1N1 influenza a pandemic in 2009.  Illness caused by SARS-CoV-2 was termed COVID-19 by the WHO, the acronym derived from "coronavirus disease 2019.
  • 7. MORPHOLOGY  Coronaviruses are enveloped, pleomorphic or spherical particles, 150 nm to 160 nm in size, linked with constructive single stranded RNA, unsegmented, nucleoprotein, capsid, matrix, and surface glycoprotein (S-protein).  Significant viral proteins are nucleocapsid protein (N), membrane (M), spike glycoprotein (S), and envelope small membrane protein (E).  COVID-19 varies from further coronaviruses by encoding a supplementary glycoprotein that Esterase and Hemagglutination (HE) properties.
  • 8. Structural protein Function(s) of protein Nucleocapsid protein (N) Bound to RNA genome to make up nucleocapsid Spike glycoprotein (S) Critical for binding of host cell receptors to facilitate entry of host cell Envelope small membrane protein (E) Interacts with M to form viral envelope Membrane protein (M) Central organizer of CoV assembly Determines shape of viral envelope Hemagglutinin-Esterase (HE) Forms a distinct inner fringe of short peplomer
  • 9.
  • 10. SYMPTOMS Most common symptoms:  Fever  Cough  Tiredness  loss of taste or smell Less common symptoms:  Sore throat  Headache  Aches and pains  Diarrhoea  Rash on skin,  Discolouration of fingers toes  Red or irritated eyes
  • 11. Serious symptoms:  Difficulty breathing or shortness of breath  Loss of speech or mobility, or confusion chest pain  Seek immediate medical attention if you have serious symptoms.  People with mild symptoms who are otherwise healthy should manage their symptoms at home.  On average it takes 5–6 days from when someone is infected with the virus for symptoms to show, however it can take up to 14 days.
  • 12. LIFE CYCLE OF COVID 19 1. Infection: So the first thing a virus has to do is to find a way to attach itself to a cell so that it can specifically get into the cell. That’s the Virus Receptor Interactions and for SARS-CoV-2 it binds to a protein called ACE-2(Angiotensin-converting enzyme 2) that is on the surface of some cells but not all cells. 2. Internalisation: Viruses then have to get inside a cell and in case of SARS- Covid it has a sort of membrane around it (Viral Lipid Membrane) that hides its genetic material from outside world. Our cells have Same kind of membrane around them that hides their genetic material from outside world.
  • 13. 3. Membrane fusion and Release of viral RNA: The virus genome when enters a cell start to find something in the host cell that is called ribosomes and ribosomes is what turns RNA into proteins.
  • 14. 4. Translation: It takes the sequence of RNA and then translates that into a protein sequence. RNA is the mean that is used to express our genes. The more the viral RNA that’s in the cell, the more that RNA will be translated into protein and faster yeh virus can take over the cell. The RNA serves two purposes. It encodes the genes that it has to complete its lifecycle but it also the way that send a message out to the cell to say” Make More of my Gene”. 5. Packaging and assembly: Then towards the end of the virus Cycle, the virus sends out its protein to a particular places within the cell that are then places where the proteins are concentrated and new virus particles are made. Presentation title 14
  • 15. TREATMENT OF COVID 19 Self care  After exposure to someone who has COVID-19, do the following:  Call your health care provider or COVID-19 hotline to find out where and when to get a test.  If testing is not available, stay home and away from others for 14 days.  While you are in quarantine, do not go to work, to school or to public places. Ask someone to bring you supplies.  Keep at least a 1-metre distance from others, even from your family members.  Wear a medical mask to protect others, including if/when you need to seek medical care.  Clean your hands frequently.  Stay in a separate room from other family members, and if not possible, wear a medical mask.  Keep the room well-ventilated.
  • 16. SELF CARE  If you share a room, place beds at least 1 meter apart.  Monitor yourself for any symptoms for 14 days.  Call your health care provider immediately if you have any of these danger signs: difficulty breathing, loss of speech or mobility, confusion or chest pain.  Stay positive by keeping in touch with loved ones by phone or online, and by exercising at home.
  • 17.
  • 18. MEDICAL CARE Scientists around the world are working to find and develop treatments for COVID-19.  Optimal supportive care includes oxygen for severely ill patients and those who are at risk for severe disease and more advanced respiratory support such as ventilation for patients who are critically ill.  Dexamethasone is a corticosteroid that can help reduce the length of time on a ventilator and save lives of patients with severe and critical illness. 18